Influence of latero-lateral versus end-to-end ileo-ascendostomy on recurrence and complications after ileocaecal resection in patients with Crohn's disease
ISRCTN | ISRCTN45665492 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN45665492 |
Secondary identifying numbers | N/A |
- Submission date
- 14/08/2008
- Registration date
- 09/10/2008
- Last edited
- 01/02/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Heinz J. Buhr
Scientific
Scientific
Charite - Universitatsmedizin Berlin
Campus Benjamin Franklin
Department of General, Vascular and Thoracic Surgery
Hindenburgdamm 30
Berlin
12200
Germany
Phone | +49 (0)30 8445 2543 |
---|---|
heinz.buhr@charite.de |
Study information
Study design | Multicentre randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | |
Study acronym | LATEND trial |
Study objectives | An important problem after surgical resection of Crohn's disease remains the high risk of recurrence. The anastomosis region is the most common localisation for recurrence and may lead to prompt reoperation. The configuration of the anastomosis is an often discussed reason for this phenomena. Wide stapled latero-lateral anastomoses appear to provide fewer relapses due to a reduced risk of re-stenosis than conventional sutured end-to-end-anastomosis, on the other hand there seems to be an increased risk of fistulas after stapled anastomosis. The existing literature on this topic has several essential deficits thus reducing their validity. Therefore a randomised controlled multicentre trial under standardised conditions is necessary to achieve a high validity to investigate the influence of latero-lateral versus end-to-end ileo-ascendostomy on recurrence and complications after ileocaecal resection in patients with Crohn's disease. |
Ethics approval(s) | Local Medical Ethics Committee gave approval on the 20th October 2005 |
Health condition(s) or problem(s) studied | Crohn's disease |
Intervention | Group one: ileocaecal resection with conventional sutured end-to-end ileo-ascendostomy Group two: ileocaecal resection with stapled latero-lateral ileo-ascendostomy The total duration of follow-up for both treatment arms is 3 years. |
Intervention type | Other |
Primary outcome measure | Endoscopic proven perianastomotic relapse of bowel inflammation one year after surgical resection (using an endoscopic relapse score). |
Secondary outcome measures | 1. Endoscopic proven perianastomotic relapse of bowel inflammation three years after surgical resection (using an endoscopic relapse score): one and three years after randomisation 2. Symptomatic perianastomotic relapse (diarrhoea, pain, fever, weight reduction, increasing inflammation parameters in blood): one and three years after randomisation 3. Relapse with indication for surgical resection: one and three years after randomisation 4. Anastomotic leaks: day of discharge from the hospital |
Overall study start date | 01/02/2006 |
Completion date | 31/10/2009 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | 224 |
Key inclusion criteria | 1. Aged greater than or equal to 18 years, either sex 2. Ileal stenosis or stricture due to Crohn's disease with indication for ileocaecal resection or right hemicolectomy 3. First perianastomotic relapse of bowel inflammation with indication for surgical resection |
Key exclusion criteria | 1. Other intestinal inflammation due to Crohn's disease 2. Aged less than 18 years 3. Pregnancy 4. Given or assumed indication for post-operative medication with azathioprine 5. Impossibility of post-operative dose reduction for cortisone medication |
Date of first enrolment | 01/02/2006 |
Date of final enrolment | 31/10/2009 |
Locations
Countries of recruitment
- Germany
Study participating centre
Charite - Universitatsmedizin Berlin
Berlin
12200
Germany
12200
Germany
Sponsor information
Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)
University/education
University/education
Campus Benjamin Franklin
Department of General, Vascular and Thoracic Surgery
Hindenburgdamm 30
Berlin
12200
Germany
Phone | +49 (0)30 8445 2543 |
---|---|
heinz.buhr@charite.de | |
Website | http://www.charite.de/ |
https://ror.org/001w7jn25 |
Funders
Funder type
Hospital/treatment centre
Charite - University Medicine Berlin (Charite - Universitatsmedizin Berlin) (Germany) - Department of General, Vascular and Thoracic Surgery, Campus Benjamin Franklin
No information available
GAST-study group (Germany)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/03/2013 | Yes | No |